Loading clinical trials...
Loading clinical trials...
A Multicenter, Non-Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered ENT-01 in Improving Constipation and Neurologic Symptoms in Patients With Parkinson's Disease and Constipation Over a 14-week Period
Conditions
Interventions
Active Investigational Treatment ENT-01
Locations
18
United States
The Parkinson's and Movement Disorder Institute
Fountain Valley, California, United States
SC3 Research - Pasadena
Pasadena, California, United States
Rocky Mountain Movement Disorders Center
Englewood, Colorado, United States
Georgetown Universtiy, Department of Neurology
Washington D.C., District of Columbia, United States
JEM Research Institute
Atlantis, Florida, United States
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida, United States
Start Date
July 30, 2020
Primary Completion Date
February 17, 2022
Completion Date
February 17, 2022
Last Updated
March 19, 2024
NCT07187843
NCT04876339
NCT04246437
NCT06692920
NCT06113640
NCT07462481
Lead Sponsor
Enterin Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions